Difference between revisions of "LncRNAWiki:R"
(Created page with "{|class="wikitable sortable" style="width:90%;text-align:center" |- !Name !Transcript ID !Alias !Description |- |''RAD51-AS1'' |RAD51-AS1 |TODRA |RAD51 antisense RNA 1 (he...") |
|||
| (2 intermediate revisions by 2 users not shown) | |||
| Line 1: | Line 1: | ||
| + | <div style="padding:0.2em 0.5em;text-align:right;font-size:125%;font-weight:bold;color:#2d2d2d;"> | ||
| + | Jump to section in alphabetical order : [[LncRNAWiki:A|'''A''']] [[LncRNAWiki:B|'''B''']] [[LncRNAWiki:C|'''C''']] [[LncRNAWiki:D|'''D''']] [[LncRNAWiki:E|'''E''']] [[LncRNAWiki:F|'''F''']] [[LncRNAWiki:G|'''G''']] [[LncRNAWiki:H|'''H''']] [[LncRNAWiki:I|'''I''']] [[LncRNAWiki:J|'''J''']] [[LncRNAWiki:K|'''K''']] [[LncRNAWiki:L|'''L''']] [[LncRNAWiki:M|'''M''']] [[LncRNAWiki:N|'''N''']] [[LncRNAWiki:O|'''O''']] [[LncRNAWiki:P|'''P''']] [[LncRNAWiki:R|'''R''']] [[LncRNAWiki:S|'''S''']] [[LncRNAWiki:T|'''T''']] [[LncRNAWiki:U|'''U''']] [[LncRNAWiki:V|'''V''']] [[LncRNAWiki:W|'''W''']] [[LncRNAWiki:X|'''X''']] [[LncRNAWiki:Y|'''Y''']] [[LncRNAWiki:Z|'''Z''']] [[LncRNAWiki:Featured|'''BACK''']] | ||
| + | </div> | ||
| + | |||
{|class="wikitable sortable" style="width:90%;text-align:center" | {|class="wikitable sortable" style="width:90%;text-align:center" | ||
|- | |- | ||
| Line 5: | Line 9: | ||
!Alias | !Alias | ||
!Description | !Description | ||
| + | !Disease | ||
|- | |- | ||
|''RAD51-AS1'' | |''RAD51-AS1'' | ||
| Line 10: | Line 15: | ||
|TODRA | |TODRA | ||
|RAD51 antisense RNA 1 (head to head) | |RAD51 antisense RNA 1 (head to head) | ||
| + | |_ | ||
|- | |- | ||
|''RASSF1-AS1'' | |''RASSF1-AS1'' | ||
| Line 15: | Line 21: | ||
|RASSF1 antisense RNA 1 | |RASSF1 antisense RNA 1 | ||
|ANRASSF1 | |ANRASSF1 | ||
| + | |breast cancer | ||
|- | |- | ||
|''RBM5-AS1'' | |''RBM5-AS1'' | ||
|[[NONHSAT089783]] | |[[NONHSAT089783]] | ||
| − | |LUCA-15-specific transcript, LUST, ENSG00000003756 | + | |"LUCA-15-specific transcript, LUST, ENSG00000003756" |
|RBM5 antisense RNA 1 | |RBM5 antisense RNA 1 | ||
| + | |_ | ||
|- | |- | ||
|''RFPL1S'' | |''RFPL1S'' | ||
|[[RFPL1S]] | |[[RFPL1S]] | ||
| − | |RFPL1-AS, NCRNA00006 | + | |"RFPL1-AS, NCRNA00006" |
|RFPL1 antisense RNA 1 | |RFPL1 antisense RNA 1 | ||
| + | |_ | ||
|- | |- | ||
|''RGMB-AS1'' | |''RGMB-AS1'' | ||
| Line 30: | Line 39: | ||
|N/A | |N/A | ||
|RGMB antisense RNA 1 | |RGMB antisense RNA 1 | ||
| + | |non-small cell lung cancer | ||
|- | |- | ||
|''RHPN1-AS1'' | |''RHPN1-AS1'' | ||
| Line 35: | Line 45: | ||
|MGC3113 | |MGC3113 | ||
|RHPN1 antisense RNA 1 (head to head) | |RHPN1 antisense RNA 1 (head to head) | ||
| + | |_ | ||
|- | |- | ||
|''RMST'' | |''RMST'' | ||
|[[RMST]] | |[[RMST]] | ||
| − | |NCRMS, NCRNA00054, LINC00054 | + | |"NCRMS, NCRNA00054, LINC00054" |
|rhabdomyosarcoma 2 associated transcript (non-protein coding) | |rhabdomyosarcoma 2 associated transcript (non-protein coding) | ||
| + | |Rhabdomyosarcoma subtypes | ||
|- | |- | ||
|''RNF217-AS1'' | |''RNF217-AS1'' | ||
| Line 45: | Line 57: | ||
|STL | |STL | ||
|RNF217 antisense RNA 1 (head to head) | |RNF217 antisense RNA 1 (head to head) | ||
| + | |_ | ||
|- | |- | ||
|''RNF219-AS1'' | |''RNF219-AS1'' | ||
| Line 50: | Line 63: | ||
|N/A | |N/A | ||
|RNF219 antisense RNA 1 | |RNF219 antisense RNA 1 | ||
| + | |_ | ||
|- | |- | ||
|''RPL34-AS1'' | |''RPL34-AS1'' | ||
|[[RPL34-AS1]] | |[[RPL34-AS1]] | ||
| − | |FLJ37673, RP11-462C24.1 | + | |"FLJ37673, RP11-462C24.1" |
|RPL34 antisense RNA 1 (head to head) | |RPL34 antisense RNA 1 (head to head) | ||
| + | |_ | ||
|- | |- | ||
|''RPS6KA2-AS1'' | |''RPS6KA2-AS1'' | ||
| Line 60: | Line 75: | ||
|N/A | |N/A | ||
|RPS6KA2 antisense RNA 1 | |RPS6KA2 antisense RNA 1 | ||
| + | |_ | ||
|- | |- | ||
|''RUSC1-AS1'' | |''RUSC1-AS1'' | ||
| Line 65: | Line 81: | ||
|FLJ35976 | |FLJ35976 | ||
|RUSC1 antisense RNA 1 | |RUSC1 antisense RNA 1 | ||
| + | |_ | ||
| + | |- | ||
| + | |''RAMP2-AS1'' | ||
| + | |[[RAMP2-AS1]] | ||
| + | |N/A | ||
| + | |RAMP2 antisense RNA 1 | ||
| + | |glioblastoma | ||
| + | |- | ||
| + | |''RASGRF2-AS1'' | ||
| + | |[[RASGRF2-AS1]] | ||
| + | |CTC-459I6 | ||
| + | |1 | ||
| + | |RASGRF2 antisense RNA 1 | ||
| + | |- | ||
| + | |''RFPL3S'' | ||
| + | |[[RFPL3S]] | ||
| + | |RFPL3-AS, NCRNA00005 | ||
| + | |RFPL3 antisense | ||
| + | |_ | ||
| + | |- | ||
| + | |''RNASEH1-AS1'' | ||
| + | |[[RNASEH1-AS1]] | ||
| + | |LOC100506054 | ||
| + | |RNASEH1 antisense RNA 1 | ||
| + | |_ | ||
|} | |} | ||
Latest revision as of 12:40, 29 June 2017
| Name | Transcript ID | Alias | Description | Disease |
|---|---|---|---|---|
| RAD51-AS1 | RAD51-AS1 | TODRA | RAD51 antisense RNA 1 (head to head) | _ |
| RASSF1-AS1 | RASSF1-AS1 | RASSF1 antisense RNA 1 | ANRASSF1 | breast cancer |
| RBM5-AS1 | NONHSAT089783 | "LUCA-15-specific transcript, LUST, ENSG00000003756" | RBM5 antisense RNA 1 | _ |
| RFPL1S | RFPL1S | "RFPL1-AS, NCRNA00006" | RFPL1 antisense RNA 1 | _ |
| RGMB-AS1 | RGMB-AS1 | N/A | RGMB antisense RNA 1 | non-small cell lung cancer |
| RHPN1-AS1 | RHPN1-AS1 | MGC3113 | RHPN1 antisense RNA 1 (head to head) | _ |
| RMST | RMST | "NCRMS, NCRNA00054, LINC00054" | rhabdomyosarcoma 2 associated transcript (non-protein coding) | Rhabdomyosarcoma subtypes |
| RNF217-AS1 | RNF217-AS1 | STL | RNF217 antisense RNA 1 (head to head) | _ |
| RNF219-AS1 | RNF219-AS1 | N/A | RNF219 antisense RNA 1 | _ |
| RPL34-AS1 | RPL34-AS1 | "FLJ37673, RP11-462C24.1" | RPL34 antisense RNA 1 (head to head) | _ |
| RPS6KA2-AS1 | RPS6KA2-AS1 | N/A | RPS6KA2 antisense RNA 1 | _ |
| RUSC1-AS1 | RUSC1-AS1 | FLJ35976 | RUSC1 antisense RNA 1 | _ |
| RAMP2-AS1 | RAMP2-AS1 | N/A | RAMP2 antisense RNA 1 | glioblastoma |
| RASGRF2-AS1 | RASGRF2-AS1 | CTC-459I6 | 1 | RASGRF2 antisense RNA 1 |
| RFPL3S | RFPL3S | RFPL3-AS, NCRNA00005 | RFPL3 antisense | _ |
| RNASEH1-AS1 | RNASEH1-AS1 | LOC100506054 | RNASEH1 antisense RNA 1 | _ |
